|
RNF167 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.718800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.329400E-01 |
| Normal-vs-Stage2 |
6.200400E-01 |
| Normal-vs-Stage3 |
2.108600E-01 |
| Normal-vs-Stage4 |
1.453590E-01 |
| Stage1-vs-Stage2 |
1.906630E-01 |
| Stage1-vs-Stage3 |
1.095810E-02 |
| Stage1-vs-Stage4 |
1.137530E-02 |
| Stage2-vs-Stage3 |
6.424400E-01 |
| Stage2-vs-Stage4 |
5.131800E-01 |
| Stage3-vs-Stage4 |
7.385800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.661200E-01 |
| Normal-vs-AfricanAmerican |
6.375800E-01 |
| Normal-vs-Asian |
1.239210E-01 |
| Caucasian-vs-AfricanAmerican |
3.335200E-01 |
| Caucasian-vs-Asian |
7.082100E-03 |
| AfricanAmerican-vs-Asian |
4.773800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.053600E-01 |
| Normal-vs-Female |
6.099900E-02 |
| Male-vs-Female |
3.45209999996765E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.481200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.894000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.637600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.327200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.007200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.749200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.352000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.038400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.093400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.791000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.585900E-02 |
| Normal-vs-Grade 2 |
5.122400E-01 |
| Normal-vs-Grade 3 |
4.241600E-01 |
| Normal-vs-Grade 4 |
1.133650E-01 |
| Grade 1-vs-Grade 2 |
1.013570E-01 |
| Grade 1-vs-Grade 3 |
2.944100E-02 |
| Grade 1-vs-Grade 4 |
8.895200E-03 |
| Grade 2-vs-Grade 3 |
8.502400E-02 |
| Grade 2-vs-Grade 4 |
2.046300E-02 |
| Grade 3-vs-Grade 4 |
3.081600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.866100E-02 |
| Normal-vs-ccB subtype |
1.293800E-02 |
| ccA subtype-vs-ccB subtype |
4.81359999637831E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.466800E-01 |
| Normal-vs-N1 |
3.099600E-02 |
| N0-vs-N1 |
6.045600E-02 |
|
|
